Nonsteroidal Antiinflammatory Drugs

New England Journal of Medicine

Volumn 302, Issue 22, 1980, Pages 1237-1243

  Koch Weser, Jan ^a   Simon, Lee S ^b   Mills, John A ^b  

^a Massachusetts General Hospital and Harvard Medical School ^*

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENOPROFEN; IBUPROFEN; MEFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC; TOLMETIN;

ADVERSE DRUG REACTION; DIGESTIVE SYSTEM; DRUG COMPARISON; GASTROINTESTINAL SYMPTOM; HEMOLYTIC ANEMIA; ORAL DRUG ADMINISTRATION; RASH; RHEUMATOID ARTHRITIS; SHORT SURVEY;

ANTI-INFLAMMATORY AGENTS; ARTHRITIS; ARTHRITIS, RHEUMATOID; FENOPROFEN; HUMAN; IBUPROFEN; MEFENAMIC ACID; NAPROXEN; PROPIONIC ACIDS; SULINDAC; SUPPORT, U.S. GOV'T, P.H.S.; TOLMETIN;

EID: 0019222434     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198005293022206     Document Type: Review

References (74)

1. Shen TY, Winter CA. Chemical and biological studies on indomethacin, sulindac, and their analogs. Adv Drug Res. 1977; 12: 90–245.
2. Duggan DE, Hare LE, Ditzler CA, Lei BW, Kwan KC. The disposition of sulindac. Clin Pharmacol Ther. 1977; 21: 326–35.
3. Kwan KC, Duggan DE. Pharmacokinetics of sulindac. Acta Rheum Belg. 1977; 1: 168–78.
4. Duggan DE, Hooke KF, Risley EA, Shen TY, Van Arman CG. Identification of the biologically active form of sulindac. J Pharmacol Exp Ther. 1977; 201: 8–13.
5. Calabro JJ, Khoury MI, Smyth CJ. Clinoril in acute gout. Acta Rheum Port. 1974; 8: 163–6.
6. Dieppe PA, Burry HC, Grahame R, Perera T. Sulindac in osteoarthrosis of the hip. Rheumatol Rehabil. 1976; 15: 112–5.
7. Huskisson EC, Franchimont P, eds. Clinoril in the treatment of rheumatic disorders. In: Proceedings of a symposium held at the 8th European Rheumatology Congress, Helsinki, Finland, 1–7 June, 1975. New York: Raven Press, 1976.
8. Green D, Given KM, Ts'ao C, Whipple JP, Rossi EC. The effect of a new non-steroidal anti-inflammatory agent, sulindac, on platelet function. Thromb Res. 1977; 10: 283–9.
9. Brooks CD, Schlagel CA, Sekhar NC, Sobota JT. Tolerance and pharmacology of ibuprofen. Curr Ther Res. 1973; 15: 180–1.
10. Boardman PL, Nuki G, Dudley-Hart F. Ibuprofen in the treatment of rheumatoid arthritis and osteo-arthritis. Ann Rheum Dis. 1967; 26: 560–1.
11. Godfrey RG, de la Cruz S. Effect of ibuprofen dosage on patient response in rheumatoid arthritis. Arthritis Rheum. 1975; 18: 135–7.
12. Huskisson EC, Woolf DL, Balme HW, Scott J, Franklyn S. Four new anti-inflammatory drugs: responses and variations. Br J Med. 1976; 1: 1048–9.
13. Darlington LG, Coomes EN. Comparison of benorylate and ibuprofen in the treatment of established rheumatoid arthritis. Rheumatol Rehabil. 1975; 14: 76–80.
14. Lewis JR. Evaluation of ibuprofen (Motrin): an new antirheumatic agent. JAMA. 1975; 233: 364–5.
15. Chan WY, Dawood MY, Fuchs F. Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid. Am J Obstet Gynecol. 1979; 135: 102–8.
16. Collum LMT, Bowen DI. Ocular side-effects of ibuprofen. Br J Ophthalmol. 1971; 55: 472–7.
17. Penner JA, Abbrecht PH. Lack of interaction between ibuprofen and warfarin. Curr Ther Res. 1975; 18: 862–71.
18. Widener HL, Littman BH. Ibuprofen-induced meningitis in systemic lupus erythematosus. JAMA. 1978; 239: 1062–4.
19. Gruber CM Jr. Clinical pharmacology of fenoprofen: a review. J Rheumatol. 1976; 3: Suppl 2: 8–17.
20. Huskisson EC, Wojtulewski JA, Berry H, Scott J, Hart FD, Balme HW. Treatment of rheumatoid arthritis with fenoprofen: comparison with aspirin. Br Med J. 1974; 1: 176–80.
21. Fries JF, Britton MC. Fenoprofen calcium in rheumatoid arthritis: a controlled double-blind crossover evaluation. Arthritis Rheum. 1973; 16: 629–34.
22. Wanasukapunt S, Lertratanakul Y, Rubinstein HM. Effect of fenoprofen calcium in acute gouty arthritis. Arthritis Rheum. 1976; 19: 933–5.
23. Brooke JW. Fenoprofen therapy in large joint osteoarthritis double-blind comparison with aspirin and long-term experience. J Rheumatol. 1976; 3: Suppl 2: 71–75.
24. Ridolfo AS, Rubin A, Crabtree RE, Gruber CM. Effects of fenoprofen and aspirin on gastrointestinal microbleeding in man. Clin Pharmacol Ther. 1973; 14: 226–30.
25. Chernish SM, Rosenak BD, Brunelle RL, Crabtree R. Comparison of gastrointestinal effects of aspirin and fenoprofen: a double blind crossover study. Arthritis Rheum. 1979; 22: 376–83.
26. Segre EJ. Naproxen metabolism in man. J Clin Pharmacol. 1975; 15: 316–23.
27. Runkel R, Forchieili R, Sevelius H, Chaplin M, Segre E. Nonlinear plasma level response to high doses of naproxen. Clin Pharmacol Ther. 1974; 15: 261–6.
28. Goldie IF, Gunterberg B, Tiselius P. An objective evaluation of naproxen for the inflammatory reaction in the rheumatoid hand: a clinical, thermographic and volumetric study. Scand J Rheumatol. 1974; 3: 161–8.
29. Wilkens RF. Double-blind crossover trial of naproxen and placebo in patients with rheumatoid arthritis. Scand J Rheumatol. 1973; 2: 132–6.
30. Szanto E. A double-blind comparison of naproxen and indomethacin in rheumatoid arthritis. Scand J Rheumatol. 1974; 3: 118–20.
31. Diamond H, Alexander S, Kuzell W, Lussier A, Odone D, Tompkins R. Naproxen and aspirin in rheumatoid arthritis: a multicenter double-blind crossover comparison study. J Clin Pharmacol. 1975; 15: 335–9.
32. Bowers DE, Dyer HR, Fosdick WM, et al. Naproxen in rheumatoid arthritis: a controlled trial. Ann Intern Med. 1975; 83: 470–5.
33. Myhal D, Camerlain M, Ménard H, Lussier A. Naproxen: long-term study in rheumatoid arthritis and “placebo pulse.” J Clin Pharmacol. 1975; 15: 327–35.
34. Mäkelä AL. Naproxen in the treatment of juvenile rheumatoid arthritis: metabolism, safety and efficacy. Scand J Rheumatol. 1977; 6: 193–205.
35. Merton JW III, Lussier A, Ward JR, Neustadt D, Multz C. Naproxen vs. aspirin in osteoarthritis of the hip and knee. J Rheumatol. 1978; 5: 338–46.
36. Sturge RA, Scott JT, Hamilton EBD, et al. Multicenter trial of naproxen and phenylbutazone in acute gout. Ann Rheum Dis. 1977; 36: 80–82.
37. Williams JGP, Engler C. A double-blind comparative trial of naproxen and indomethacin in sports injuries. Rheumatol Rehabil. 1977; 16: 265–9.
38. Pulkkinen MO, Henzl MR, Csapo AI. The effect of naproxen-sodium on the prostaglandin concentrations of the menstrual blood and uterine “jet washings” in dysmenorrheic women. Prostaglandins. 1978; 15: 543–50.
39. Willkens RF, Segre EJ. Combination therapy with naproxen and aspirin in rheumatoid arthritis. Arthritis Rheum. 1976; 19: 677–82.
40. Halvorsen L, Dotevall G, Sevelius H. Comparative effects of aspirin and naproxen on gastric mucosa. Scand J Rheumatol [Suppl]. 1973; 2: 43–47.
41. Matts SGF. Naproxen (Naprosyn) and gastrointestinal haemorrhage. Br Med J. 1974; 2: 52.
42. Hart FD. Naproxen (Naprosyn) and gastrointestinal haemorrhage. Br Med J. 1974; 2: 51–52.
43. Lehtola J, Sipponen P. A gastroscopic and histological double-blind study of the effects of diclofenac sodium and naproxen on the human gastric mucosa. Scand J Rheumatol. 1977; 6: 97–102.
44. Roth SH, Boost G. An open trial of naproxen in rheumatoid arthritis patients with significant esophageal, gastric, and duodenal lesions. J Clin Pharmacol. 1975; 15: 378–84.
45. Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery TM. Naproxen: review of its pharmacological properties, therapeutic efficacy, and use. Drugs. 1975; 9: 326–63.
46. Selley ML, Glass J, Triggs EJ, Thomas J. Pharmacokinetic studies of tolmetin in man. Clin Pharmacol Ther. 1975; 17: 599–605.
47. Berkowitz SS, Bernhard G, Bilka PJ, et al. Tolmetin versus placebo for treatment of rheumatoid arthritis: a sequential double-blind clinical trial. Curr Ther Res. 1974; 16: 442–51.
48. Caldwell J, Brandon ML, Franz KH, Clark GM, Ricca LR. A double-blind comparison of the efficacy and side effect liability of tolmetin and indomethacin. In: Ward JR, ed. Tolmetin. Amsterdam: Excerpta Medica, 1975:71–84.
49. Robinson H, Abruzzo JL, Miyara A, Ward JR. Concomitant tolmetin and aspirin therapy for rheumatoid arthritis. In: Ward JR, ed. Tolmetin. Amsterdam: Excerpta Medica, 1975:102–11.
50. Beirne J, Bianchine J, Johnson PC, Wortham GF. Gastrointestinal blood loss caused by tolmetin, aspirin and indomethacin. Clin Pharmacol Ther. 1974; 16: 821–5.
51. Ehrlich GE, Roth S. Rheumatoid arthritis: long-term therapy with tolmetin sodium. Orthop Dig. 1976; 4: 16–24.
52. Sakai J, Joseph MW. Tolmetin and agranulocytosis. N Engl J Med. 1978; 298: 1203.
53. Mielke CH, Heiden D, Amadio P Jr. Tolmetin: hematological effects in normal subjects. In: Ward JR, ed. Tolmetin. Amsterdam: Excerpta Medica, 1975:200–8.
54. Tolman EL, Partridge R. Multiple sites of interaction between prostaglandins and non-steroidal anti-inflammatory agents. Prostaglandins. 1975; 9: 349–59.
55. Barnardo DE, Currey HLF, Mason RM, Fox WR, Weatherall M. Mefenamic acid and flufenamic acid compared with aspirin and phenylbutazone in rheumatoid arthritis. Br Med J. 1966; 2: 342–3.
56. Budoff PW. Use of mefenamic acid in the treatment of primary dysmenorrhea. JAMA. 1979; 241: 2713–6.
57. Rejholec V, Vapaatalo H, Tokola O, Gothoni G. Tolfenamic acid in the treatment of rheumatoid arthritis. Scand J Rheumatol [Suppl]. 1979; 24: 9–12.
58. Zachariae E, Sylvest J. Osteoarthritis of the knee treated with tolfenamic acid. Scand J Rheumatol. 1972; 1: 97–99.
59. Axelsson CK, Christiansen LV, Johanson A, Poulsen PE. Comparative effects of tolfenamic acid and acetylsalicylic acid on human gastric mucosa. Scand J Rheumatol. 1977; 6: 23–27.
60. Cathcart BJ, Vince JD, Gordon AJ, Bell MA, Chalmers IM. Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). Ann Rheum Dis. 1973; 32: 62–65.
61. Gyory AN, Bloch M, Burry HC, Grahame R. Orudis in management of rheumatoid arthritis and osteoarthritis of the hip: comparison with indomethacin. Br Med J. 1972; 4: 398–400.
62. Montrone F, Fumagalli M, Pellegrini P, et al. A double-blind crossover evaluation of ketoprofen (Orudis) and ibuprofen in the management of rheumatoid arthritis. Rheumatol Rehabil. 1979; 18: 114–8.
63. Magnusson B, Sölvell L, Arvidsson B. A comparative study of gastrointestinal bleeding during administration of ketoprofen and naproxen. Scand J Rheumatol. 1977; 6: 62–64.
64. Zutshi DW, Stern D, Bloch M, Mason RM. Ketoprofen: double-blind crossover study with indomethacin in patients with rheumatoid arthritis. Rheumatol Rehabil. 1974; 13: 10–16.
65. Larizza D, Columbo A, Lorini R, Severi F. Ketoprofen causing pseudotumor cerebri in Bartter's syndrome. N Engl J Med. 1979; 300: 796.
66. Huskisson EC, Scott J. Treatment of rheumatoid arthritis with a single daily dose of benoxaprofen. Rheumatol Rehabil. 1979; 18: 110–3.
67. Huskisson. Analgesic and anti-inflammatory properties of indoprofen. Rheumatol Rehabil. 1979; 18: 49–52.
68. Valtonen EJ. Clinical comparison of fenbufen and aspirin in osteoarthritis. Scand J Rheumatol [Suppl]. 1979; 27: 3–7.
69. Davis JD, Struth AG, Turner RA, Pisko EJ, Ruchte IR. Pirprofen and aspirin in the treatment of rheumatoid arthritis. Clin Pharmacol Ther. 1979; 25: 618–23.
70. Luders RC, Maggio-Cavaliere MB, Egger H, et al. Disposition of pirprofen, a new anti-inflammatory drug. Clin Pharmacol Ther. 1977; 21: 721–30.
71. Lassman HB, Wilker JC, Anderson VB, Agnew MN, Allen RC, Novick WJ Jr. Fendosal (HP 129): a potent anti-inflammatory and analgesic compound. Agents Actions. 1978; 8: 209–17.
72. Proquazone: a new non-steroidai anti-inflammatory drug. Scand J Rheumatol [Suppl]. 1978; 21: 1–42.
73. Doreen MS, Boardman PL, Fowler PD, Poole PH. Diclofenac (Voltarol) in rheumatoid arthritis: a report of a double-blind trial. Rheumatol Rehabil. 1978; 17: 95–102.
74. Buckingham RB. Interactions involving antirheumatic agents. Bull Rheum Dis. 1977; 28: 960–5.